CrestPoint Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $1.08M | Hold |
3,400
| – | – | 0.6% | 55 |
|
|
2017
Q3 | $1.07M | Sell |
3,400
-500
| -13% | -$157K | 0.47% | 73 |
|
|
2017
Q2 | $1.06M | Sell |
3,900
-115
| -3% | -$31.2K | 0.5% | 69 |
|
|
2017
Q1 | $1.1M | Buy |
4,015
+415
| +12% | +$113K | 0.52% | 60 |
|
|
2016
Q4 | $1.02M | Hold |
3,600
| – | – | 0.51% | 61 |
|
|
2016
Q3 | $1.13M | Buy |
3,600
+200
| +6% | +$62.6K | 0.58% | 53 |
|
|
2016
Q2 | $822K | Sell |
3,400
-400
| -11% | -$96.7K | 0.44% | 87 |
|
|
2016
Q1 | $989K | Hold |
3,800
| – | – | 0.54% | 59 |
|
|
2015
Q4 | $1.16M | Sell |
3,800
-1,200
| -24% | -$368K | 0.66% | 46 |
|
|
2015
Q3 | $1.46M | Sell |
5,000
-1,500
| -23% | -$438K | 0.84% | 33 |
|
|
2015
Q2 | $2.63M | Hold |
6,500
| – | – | 1.39% | 7 |
|
|
2015
Q1 | $2.75M | Buy |
6,500
+2,655
| +69% | +$1.12M | 1.43% | 8 |
|
|
2014
Q4 | $1.31M | Buy |
3,845
+645
| +20% | +$219K | 0.71% | 38 |
|
|
2014
Q3 | $1.06M | Hold |
3,200
| – | – | 0.64% | 56 |
|
|
2014
Q2 | $1.01M | Sell |
3,200
-200
| -6% | -$63.1K | 0.59% | 65 |
|
|
2014
Q1 | $1.04M | Hold |
3,400
| – | – | 0.65% | 51 |
|
|
2013
Q4 | $951K | Buy |
+3,400
| New | +$951K | 0.63% | 55 |
|